期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

过渡金属配合物与DNA作用的研究状况和应用

Research and Application of Transition Metal Complexes with DNA
下载PDF
导出
摘要 文章对过渡金属配合物与DNA相互作用的研究和应用进行了归纳和分析,在过渡金属配合物可用于DNA分子光开关、DNA二级结构探针、DNA错配碱基识别探针、DNA切割试剂等方面进行了总结和探索。 In the paper, analysis of interactions between transition metal complexes and DNA was summarized. The transition metal complexes can be used for DNA molecular light switch, DNA secondary structure probe, DNA probes to identify base pair mismatches, DNA cleavage reagents, etc. Those applications were studied and explored.
作者 王海滔
机构地区 深圳大学化学与化工学院
出处 《广东化工》 CAS 2009年第9期86-89,共4页 Guangdong Chemical Industry
关键词 过渡金属配合物 DNA 研究状况 应用 transition metal complexes DNA research application
分类号 O641.4 [理学—物理化学] Q523.03 [生物学—生物化学]
  • 相关文献

参考文献40

  • 1巢晖,高峰,计亮年.钌(Ⅱ)多吡啶配合物与DNA相互作用研究[J].化学进展,2007,19(12):1844-1851. 被引量：15
  • 2Jennette K W, Lippard S J, Vassiliades G A, et al. Metallointercalation Reagents . 2-Hydroxyethanethiolato(2,2 ',2 "-terpyridine)- platinum(Ⅱ) Monocation Binds Strongly to DNA By Intercalation[J]. Proc.Nat.Acad.Sci.U.S.A., 1974, 71: 3839.
  • 3Barton J K, Dannenberg J J, Raphael A L. Enantiomeric selectivity in binding tris(phenanthroline) zinc(Ⅱ) to DNA[J]. J. Am. Chem. Soc., 1982, 104(18): 4967-4969.
  • 4Barton J K, Danishefsky A T, Goldberg J M. Tris(phenanthroline) mthenium(Ⅱ): stereoselectivity in binding to DNA[J]. J. Am. Chem Soc., 1984, 106: 2172-2176.
  • 5Barton J K . Metals and DNA : molecular left-handed complements[J]. Science, 1986, 233(4765): 727-34.
  • 6Kumar C V , Barton J K, Turro N J. Photophysics of ruthenium complexes bound to double helical DNA[J]. J. Am. Chem. Soc., 1985, 107: 5518-5523.
  • 7Pyle A M, Rebmann J P, Meshoyer R, et al. Mixed-ligand complexes of ruthenium(II) : factors governing binding to DNA[J]. J. Am. Chem. Soc., 1989,111(8): 3051-3058.
  • 8Zhang J, Qi H L, Li Y, et al. Electrogenerated Chemiluminescence DNA Biosensor Based on Hairpin DNA Probe Labeled with Ruthenium Complex[J]. Anal. Chem., 2008, 80(8): 2888-2894.
  • 9Rueba E, Hart J R, Barton J K. [Ru(bpy)2(L)]Cl2: Luminescent Metal Complexes That Bind DNA Base Mismatches[J]. Inorg.Chem., 2004, 43: 4570-4578.
  • 10Bichenkova E V, Yu X, Bhadra P, et al. DNA Mismatch Detection by Resonance Energy Transfer between Ruthenium(Ⅱ) and Osmium(Ⅱ) Tris(2,2'-bipyridyl) Chromophores[J]. Inorg. Chem. , 2005, 44(12): 4112-4114.

二级参考文献111

  • 1Smith, O'Brien, Talbot, et al. Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol, 2001,19(5):1336
  • 2Rauko, Novotny, Dovinova, et al. Ntitumor activity of benzamide riboside and its combination with cisplatin and staurosporine. Eur J Pharm Sci, 2001,12(4) :387
  • 3Sandler , Bhimma R, Coovadia M, et al. Irinotecan: future directions in small-cell lung cancer. Clin Lung Cancer, 2001 ,S2:9
  • 4Bogush,Konukhova,Tillmann H L. Inhibition of ABC-transporter (s)' function in non-small cell lung cancer cells by platinum drugs.Antibiot Khimioter, 2003,48(10): 11
  • 5Meric,Rixe,Khayat. Metastatic malignant melanoma. Drugs Today (Barc), 2003,39 (S-C) : 17
  • 6Curran , Sawayama Y, Hayashi J. Combined-modality therapy for inoperable non-small-cell lung cancer using gemcitabine. Clin Lung Cancer, 2002,3:S17
  • 7Janne , Skarin, Gucer S. Concurrent docetaxel and thoracic radiation in non-small-cell lung cancer. Clin Lung Cancer, 2002,3 (2):S37
  • 8Rosell, Taron , O'Brate et al. Predictive molecular markers in non-small cell lung cancer. Curr Opin Oncol, 2001,13 (2): 101
  • 9Loehrer , Wick J. Thymic malignancies in non-small cell lung cancer. Cancer Treat Res, 2001,105 (2): 277
  • 10Nishioka, Kawakami Y, Adhikari M. Duration of chemotherapy in advanced non-small-cell lung cancer. Jpn J Cancer Chemother,1994,19(3):120

共引文献22

广东化工
2009年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部